| Report ID | 275276 |
| Drug Identification Number | 02440296 |
| Brand name | NAT-ESCITALOPRAM |
| Common or Proper name | ESCITALOPRAM |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESCITALOPRAM |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BOTTLE |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2026-01-05 |
| Remaining supply date | 2026-01-05 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Rebranded the product to NATCO-Escitalopram |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-06 | French | Compare |
| v1 | 2026-01-06 | English | Compare |
Showing 1 to 2 of 2